Sponsor or institution

Clinical trials and research at Medtronic Cardiac Ablation Solutions

• 7Clinical trials
• 20Countries

Newest trials

All recruiting trials (7)

• Sphere VT: Using Sphere-9 Catheter and Affera System to treat recurrent scar-related ventricular tachycardia

  This study tests the Sphere-9 catheter and Affera mapping and ablation system in adults with recurring scar-related ventricular tachycardia after a prior heart attack.

  Recruiting at 5 sites Medtronic Cardiac Ablation Solutions · Littleton, Colorado and 6 other locations · NCT07585968

• Redo AF ablation using the Sphere-9 catheter and Affera system for recurrent paroxysmal and persistent atrial fibrillation

  The study will try the Sphere-9 catheter with the Affera ablation and mapping systems for adults who have symptomatic recurrent paroxysmal or persistent atrial fibrillation after one prior ablation.

  Recruiting at 24 sites Medtronic Cardiac Ablation Solutions · Birmingham, Alabama and 29 other locations · NCT07298473

• Assessing a new catheter and ablation system for treating ventricular tachycardia

  This study is testing a new catheter and ablation system to see if it can help adults with recurring ventricular tachycardia feel better after their heart problems.

  Recruiting at 6 sites Medtronic Cardiac Ablation Solutions · Boston, Massachusetts and 5 other locations · NCT06703489

• Observational study on the PulseSelect PFA System for treating Atrial Fibrillation

  This study is testing whether the PulseSelect PFA System can effectively treat people with recurring Atrial Fibrillation and how safe it is over three years.

  Recruiting at 19 sites Medtronic Cardiac Ablation Solutions · Tampa, Florida and 22 other locations · NCT06578104

• Registry for patients treated with the PulseSelect™ PFA System for atrial fibrillation

  This study is tracking how well and safely the PulseSelect™ PFA System works for treating atrial fibrillation in a variety of patients over at least a year after their procedure.

  Recruiting at 2 sites Medtronic Cardiac Ablation Solutions · Richmond, Victoria and 42 other locations · NCT06393920

• Using the SpherePVI™ Catheter to treat paroxysmal atrial fibrillation

  This study tests if the SpherePVI™ Catheter can safely help people with paroxysmal atrial fibrillation who haven't found relief with regular medications.

  Recruiting Medtronic Cardiac Ablation Solutions · Vilnius · NCT05144503

• Using the Affera SpherePVI™ System to Treat Atrial Fibrillation

  This study is testing a new device to see if it can safely help people with paroxysmal atrial fibrillation feel better by using a procedure called catheter ablation.

  Recruiting at 2 sites Medtronic Cardiac Ablation Solutions · Prague and 1 other locations · NCT05115214

Quick answers

How many clinical trials run by Medtronic Cardiac Ablation Solutions are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in United States (4 trials), Australia (2 trials), Belgium (2 trials), Canada (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →